Foster NEXThaler 100/6 mikrograma po inhalaciji, prašak inhalata

Name	Foster NEXThaler 100/6 mikrograma po inhalaciji, prašak inhalata
Former Name	Foster NEXThaler 100/6 mikrograma po dozi, prašak inhalata
Marketing Authorisation Number	HR-H-424823653
Active Substance	beklometazondipropionat formoterolfumarat dihidrat
Composition	jedna odmjerna doza od 10 mg praška inhalata sadrži: 100 mikrograma beklometazondipropionata i 6 mikrograma formoterolfumarat dihidrata, što odgovara isporučenoj dozi od 81,9 mikrograma beklometazondipropionata i 5,0 mikrograma formoterolfumarat dihidrata.
Pharmaceutical Form	prašak inhalata
Manufacturer	Chiesi Pharmaceuticals GmbH, Beč, Austrija Chiesi Farmaceutici S.p.A., Parma, Italija
Marketing Authorisation Holder	Chiesi Pharmaceuticals GmbH, Gonzagagasse 16/16, Beč, Austrija
Marketing Authorisation Date	22.07.2022
MA Period of Validity	unlimited
Classification Number	UP/I-530-09/21-02/174
Registration Number	381-12-01/70-22-03
Prescription	na recept
Type of prescription	ponovljivi recept
Distribution	u ljekarni
Advertising to general public	zabranjeno
ATC Code	R03AK08
Medicinal product marketed in the Croatia	Da
SmPC	download
PL	download

Packaging description	MA Number for Packaging	Marketing status	Shortage status
1 inhalator sa 120 doza u zaštitnoj vrećici, u kutiji	HR-H-424823653-01	-	-
2 inhalatora sa 120 doza u zaštitnoj vrećici, u kutiji	HR-H-424823653-02	-	-
3 inhalatora sa 120 doza u zaštitnoj vrećici, u kutiji	HR-H-424823653-03	-	-
1 inhalator sa 180 doza u zaštitnoj vrećici, u kutiji	HR-H-424823653-04	-	-
2 inhalatora sa 180 doza u zaštitnoj vrećici, u kutiji	HR-H-424823653-05	-	-
3 inhalatora sa 180 doza u zaštitnoj vrećici, u kutiji	HR-H-424823653-06	-	-

Medicinal Products